Author

G. A. Sulikowski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A. G. Waterson· 2 shared A. C. Doran· 1 shared A. N. Jenkins· 1 shared A. Pozzi· 1 shared A.-M. Alli-Oluwafuyi· 1 shared B. C. Paria· 1 shared B. I. Reinfeld· 1 shared B. J. Reisman· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. G. Waterson

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy

S. Siricilla, C. J. Hansen, J. H. Rogers, D. De, C. L. Simpson, A. G. Waterson, G. A. Sulikowski, S. L. Crockett, N. Boatwright, J. J. Reese, B. C. Paria, J. M. Newton, J. L. Herington

This study evaluates the tocolytic efficacy of mundulone and its analog MA, showing synergism with atosiban and demonstrating their potential to delay preterm labor in mice.

bioRxiv · Jun 6, 2023Pharmacology & Toxicology

Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages

J. E. Zarrow, A.-M. Alli-Oluwafuyi, C. M. Youwakim, K. Kim, A. N. Jenkins, I. C. Suero, M. R. Jones, Z. Mashhadi, K. P. Mackie, A. G. Waterson, A. C. Doran, G. A. Sulikowski, S. S. Davies

This study identifies small molecule activators of NAPE-PLD that enhance efferocytosis by macrophages, suggesting their potential therapeutic use in cardiometabolic diseases.

bioRxiv · Jan 25, 2023Biochemistry

The 5-LOX/COX-2 cross-over metabolite, hemiketal E2, enhances VEGFR2 activation and promotes angiogenesis

F. Nakashima, J. A. Gimenez-Bastida, P. B. Luis, S. H. Presley, R. E. Boer, M. Chiusa, T. Shibata, G. A. Sulikowski, A. Pozzi, C. Schneider

This study identifies HKE2, a cross-over metabolite of 5-LOX and COX-2, as a pro-angiogenic agent that activates VEGFR2 and promotes angiogenesis in vitro and in vivo.

bioRxiv · May 13, 2022 · PreprintPharmacology & Toxicology

A Family of Glycosylated Macrolides Selectively Target Energetic Vulnerabilities in Leukemia

B. J. Reisman, H. Guo, H. E. Ramsey, M. T. Wright, B. I. Reinfeld, P. B. Ferrell, G. A. Sulikowski, W. K. Rathmell, M. R. Savona, L. Plate, J. L. Rubinstein, B. O. Bachmann

This study identifies the mitochondrial ATP synthase as the target of apoptolidin family glycomacrolides and demonstrates their efficacy in suppressing leukemia progression.

bioRxiv · May 31, 2021Biochemistry